Frazier Life Sciences
Frazier Life Sciences Raises $1.3 Billion Amid Biotech Downturn
Frazier Life Sciences; venture capital; biotech; $1.3 billion raise; early-stage investments; biopharmaceutical startups; oversubscribed fund; therapeutics
Frazier Life Sciences Boosts Evergreen Fund with $630M for Small and Mid-Cap Biotechs
Frazier Life Sciences, Evergreen Fund, Small and Mid-Cap Biotechs, Healthcare Investment, Biotechnology Funding